CVS Health Corporation (CVS.MX)

Mexico - Mexico Delayed Price. Currency in MXN
1,794.50+20.50 (+1.16%)
At close: 2:53 PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1,774.00
Bid1,620.00 x 200
Ask0.00 x 5000
Day's Range1,772.10 - 1,795.74
52wk Range1,499.30 - 1,930.00
1y Target EstN/A
Market Cap1.91T
P/E Ratio (ttm)412.81
Avg Vol (3m)3,107
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • TheStreet.com3 days ago

    Will CVS Health (CVS) Stock Be Hurt by Delayed Curbside Service?

    CVS Health (CVS) is putting its curbside delivery program on hold after the company's app was backlogged with orders, causing it to significantly slow down.

  • Forbes3 days ago

    Does IRS Exelon Win Threaten Triple Net 1031 Deals?

    Here is the problem they faced. In order for the economics of this deal,other than tax benefits, to work there did not have to be an actual power plant involved. After all, Unicom is getting 77% of the money back in six months and there is an insurance company guaranteeing that they will get more than 100% of the money in a little over thirty years and probably not by coincidence the timing is such that they could defer the back end money with another 1031 deal. So with those contractual guarantees, the power plant Unicom bought from CPS could have been a fourth grade science project coil of copper ...

  • Reuters3 days ago

    UnitedHealth trims drug coverage, including Sanofi insulin

    In a bulletin seeking client feedback by Sept. 28, UnitedHealth said it is changing reimbursement terms for long-acting insulins and will no longer cover Lantus, the main insulin drug sold by Sanofi (SASY.PA). The insurer said Basaglar, a cheaper biosimilar insulin sold by Eli Lilly (LLY.N) would be covered as "Tier 1," meaning the lowest out-of-pocket costs for members. Levemir, produced by Novo Nordisk (NOVOb.CO), will move from Tier 1 to Tier 2.